Premium
AbCellera Biologics Inc (ABCL)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575,... AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.03 | 18.3600713012 | 5.61 | 6.71 | 5.3301 | 7798481 | 5.79920236 | CS |
| 4 | 1.25 | 23.1910946197 | 5.39 | 6.79 | 5.01 | 6705988 | 5.78835133 | CS |
| 12 | 3.21 | 93.5860058309 | 3.43 | 6.79 | 3.22 | 7162960 | 4.88160265 | CS |
| 26 | 2.92 | 78.4946236559 | 3.72 | 6.79 | 2.745 | 5389876 | 4.40239837 | CS |
| 52 | 2.66 | 66.8341708543 | 3.98 | 6.79 | 2.745 | 5273562 | 4.46086504 | CS |
| 156 | -0.64 | -8.79120879121 | 7.28 | 8.05 | 1.8906 | 3392181 | 4.00160412 | CS |
| 260 | -14.48 | -68.5606060606 | 21.12 | 22.64 | 1.8906 | 2899479 | 6.19279473 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
